TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53

Yinxiang Lv1 Department of Oncology, Xinchang People’s Hospital, ShaoxingCorrespondence[email protected]

Yanan Huo2 Eye Centre, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou

Xican Yu1 Department of Oncology, Xinchang People’s Hospital, Shaoxing

Rongrong Liu3 Department of Cell Biology and Medical Genetics, Research Center of Molecular Medicine, National Education Base for Basic Medical Sciences, Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

Shufen Zhang3 Department of Cell Biology and Medical Genetics, Research Center of Molecular Medicine, National Education Base for Basic Medical Sciences, Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

Xiaoxiao Zheng3 Department of Cell Biology and Medical Genetics, Research Center of Molecular Medicine, National Education Base for Basic Medical Sciences, Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

Xianning Zhang3 Department of Cell Biology and Medical Genetics, Research Center of Molecular Medicine, National Education Base for Basic Medical Sciences, Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

show all

TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date